155 related articles for article (PubMed ID: 29503566)
1. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.
Sheng XR; Xing SG; Wang RD; Chen K; Jia WD
Onco Targets Ther; 2018; 11():909-917. PubMed ID: 29503566
[TBL] [Abstract][Full Text] [Related]
2. Low
Cheng Y; Xing SG; Jia WD; Huang M; Bian NN
Onco Targets Ther; 2017; 10():47-54. PubMed ID: 28031722
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.
Fu RD; Qiu CH; Chen HA; Zhang ZG; Lu MQ
Tumour Biol; 2014 Aug; 35(8):7603-10. PubMed ID: 24798975
[TBL] [Abstract][Full Text] [Related]
6. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
8. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
9. TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma.
Yan Y; Chen Z; Liao Y; Zhou J
Oncol Lett; 2019 Jun; 17(6):5073-5079. PubMed ID: 31186719
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Chen XQ; He JR; Wang HY
Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
[TBL] [Abstract][Full Text] [Related]
11. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
12. Expression of LAMP3 and its correlation with clinicopathologic characteristics and prognosis in hepatocellular carcinoma.
Gui Y; Liu WB; Chen H; Ma JL; Li JS
Int J Clin Exp Pathol; 2018; 11(1):367-374. PubMed ID: 31938120
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.
Zhao ZK; Yu HF; Wang DR; Dong P; Chen L; Wu WG; Ding WJ; Liu YB
World J Gastroenterol; 2012 Dec; 18(45):6651-6. PubMed ID: 23236241
[TBL] [Abstract][Full Text] [Related]
15. [Significance of expression of Myc-induced nuclear antigen 53 in hepatocellular carcinoma and its relationship with patient prognosis].
Ye DX; Zhou X; Yang Q; Hu XY; Li H; Xiang FG
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):259-265. PubMed ID: 32306660
[No Abstract] [Full Text] [Related]
16. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
18. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
19. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
20. Low MARCO Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma Following Liver Transplantation.
Zhang Q; Wei Y; Li Y; Jiao X
Cancer Manag Res; 2022; 14():1935-1944. PubMed ID: 35720642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
